Home
Eris Lifesciences Ltd Board of Directors
Board of Directors at ERIS Lifesciences Ltd
Chairman & Managing Director
Whole-time Director
Independent Non Exe. Director
Whole-time Director
Whole Time Director & COO
Key Highlights
- Amit Indubhushan Bakshi joins the board as Chairman & Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Kaushal Kamlesh Shah joins the board as Whole-time Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Inderjeet Singh Negi joins the board as Whole-time Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Krishnakumar Vaidyanathan joins the board as Whole Time Director & COO, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sujesh Vasudevan continues to serve as the Independent Non Exe. Director in 2024, maintaining the same position as in the previous year.

ERIS Lifesciences Ltd
NSE: ERIS
Share Price
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 1381.7 |
16 Apr 2025 | 1397.2 |
15 Apr 2025 | 1379.05 |
11 Apr 2025 | 1384.5 |
09 Apr 2025 | 1364.05 |
08 Apr 2025 | 1321.05 |
07 Apr 2025 | 1275.2 |
04 Apr 2025 | 1319.7 |
03 Apr 2025 | 1367.45 |
02 Apr 2025 | 1374.2 |
Company Fundamentals for ERIS Lifesciences Ltd
Market Cap
18,813 Cr
EPS
24.2
P/E Ratio (TTM)
57.1
P/B Ratio (TTM)
6.8
Day’s High
1397.95
Day’s Low
1373.4
DTE
1.0
ROE
12.6
52 Week High
1593.0
52 Week Low
815.5
ROCE
11.0
Market Price of ERIS Lifesciences Ltd
1M
1Y
3Y
5Y
ERIS Lifesciences Ltd News Hub
ERIS Lifesciences to convene AGM
ERIS Lifesciences announced that the 18th Annual General Meeting (AGM) of the company will be held o
Read more
05 Aug 24
ERIS Lifesciences consolidated net profit declines 12.31% in the June 2024 quarter
Net profit of ERIS Lifesciences declined 12.31% to Rs 83.18 crore in the quarter ended June 2024 as
Read more
02 Aug 24
ERIS Lifesciences announces board meeting date
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 25 October 2024. P
Read more
22 Oct 24
ERIS Lifesciences to hold board meeting
ERIS Lifesciences will hold a meeting of the Board of Directors of the Company on 4 February 2025. P
Read more
29 Jan 25